(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
6 Natural products High In Vitamins,Which One Do You Like to Eat - 2Teen drug use remains low, but survey finds small rise in heroin and cocaine use
- 3Dirty soda started as a Mormon alternative to booze. Now it's everywhere.
- 4Manual for Notorious Fragrances: Immortal Aromas
- 5Thousands of New York City nurses set to strike Monday if deal isn't reached with hospitals
- Vote in favor of Your #1 4\u00d74 SUVs
- How to disinfect if the stomach bug hits your home
- Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial
- How to watch ‘The Traitors’ Season 4: Premiere date, episode release time, full cast list and more
- Remote Headphones: Upgrade Your Sound Insight
- FDA approves Wegovy pill for weight loss
- West Antarctica’s history of rapid melting foretells sudden shifts in continent’s ‘catastrophic’ geology
- This Luxurious Thermal Spa In Italy Is Perfect For A Relaxing Escape While Visiting Milan
- See as Your #1: These Low-Sugar Food sources You Ought to Attempt
